Aberrant activation of the CD8+ T cell/IFN-γ axis is closely associated with thrombocytopenia, disease recurrence, and severity in pediatric ITP, and may serve as a potential immune-targeted intervention candidate for refractory ITP.
Abstract
Background Primary immune thrombocytopenia (ITP) represents the most common acquired bleeding disorder among children. Since its immune mechanism is not fully clarified, precise immune markers still need to be identified for guiding and intervening in recurrent and refractory cases. Methods This cross-sectional study included children diagnosed with ITP between August 2022 and November 2024. Peripheral blood levels of CD3+ T, CD4+ T, CD8+ T, and B cells were quantified via flow cytometry analysis. Intracellular IFN-γ expression was analyzed. Spearman correlation analysis was conducted in combination with platelet count and WHO bleeding score. Results Compared with healthy controls, children with ITP exhibited a markedly reduced platelet count and elevated bleeding frequency (both P < 0.0001). The proportion of CD8+ T cells significantly increased in both the relapse group and the severe group, and the CD4+/CD8+ ratio decreased in the severe group. The proportions of CD3−IFN-γ cells, CD4+ IFN-γT cells, and CD8+ IFN-γT cells were all higher in ITP children than in healthy controls, with higher CD3+ CD8+ IFN-γT cells expression detected in the severe group (all P < 0.05). Platelet was negatively correlated with the proportion of CD3+ CD8+ IFN-γT cells (r = −0.2583, P = 0.012). Conclusion Aberrant activation of the CD8+ T cell/IFN-γ axis is closely associated with thrombocytopenia, disease recurrence, and severity in pediatric ITP, and may serve as a potential immune-targeted intervention candidate for refractory ITP.
Immune thrombocytopenia (ITP) is an immune-mediated disorder characterized by decreased platelet count resulting from immune dysregulation and altered cellular immune responses. This study aimed to evaluate monocyte–macrophage polarization patterns and the expression of immune checkpoint molecules CD273 (PD-L2) and CD2...
Asmaa M. Zahran, O. El-Badawy, M. Youssef et al.· Blood Research· 0 citations
CD38+HLA-DR+CD8+ T cells are identified as a potential mechanistic link between Still's disease and MAS and highlight this subset as a candidate therapeutic target.
Greta Rogani, R. Erkens, A. Bodelón et al.· Arthritis & Rheumatology· 0 citations
Objectives B‐cell aggregates below the meninges have been associated with progression of neurodegeneration in multiple sclerosis (MS). We aimed to investigate the frequency of different B‐cell subsets and their relationship with MS severity. Also, we quantified the CXCL13 and neurofilament (NfL) plasma levels. Methods...
L. Lopes, Marcos O. S. Cafasso, Joana Hygino et al.· Journal of Immunological Res...· 0 citations
BACKGROUND
T lymphocytes play a crucial role in the development of hypertension and associated end-organ damage. CD38 is a well-established surface marker for T-cell activation. However, clinical evidence linking CD38+ T cells, or other specific T-cell subsets, with blood pressure (BP) changes remains limited. We there...